loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2230302 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) (1)

filter

01 PURDUE PHARMA (1)

filter

01 TABLET (EXTENDED-RELEASE) (1)

filter

01 50MG (1)

filter

01 Canada (1)

URL Supplier Web Content
TABLET (EXTENDED-RELEA...
50MG
CODEINE CONTIN 50MG CO...
Canada
2230302
50
Narcotic (CDSA I)
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2230302

Looking for CTD TGA MCC DOSSIER APPLICATION 2230302 1

19

Purdue Pharma, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE), with a corresponding application number 2230302 and regulatory information .

proudly manufactured in the

Purdue Pharma's CODEINE CONTIN 50MG CONTROLLED RELEASE TAB TABLET (EXTENDED-RELEASE), medication with 50MG of CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE).

Post Enquiry
POST ENQUIRY